Do You Know That Tangerines May Protect the Body From Coronary Artery Disease?
An article on Everyday Health.com highlights the metabolic benefits of tangerines, labeling them as metabolic masters.
Research from the University of Western Ontario, as reported in Science Daily, suggests that a flavonoid, a type of antioxidant found in this citrus fruit, may provide protection against the trio of diseases collectively known as metabolic syndrome coronary artery disease, stroke, and type 2 diabetes. In experiments where mice were fed a typical “western” diet (high in fat and refined sugar) supplemented with the tangerine antioxidant nobiletin, the mice experienced no increase in cholesterol, triglycerides, insulin, or blood sugar. Conversely, mice without nobiletin supplementation saw a rise in these factors. Additionally, long-term animal studies have indicated that this compound prevents atherosclerosis, the hardening of arteries linked to heart attacks or strokes.
Tangerines may also play a role in cancer prevention when the peel is consumed. A British study discovered that a compound in the peel, salvestrol Q40, inhibits the activity of an enzyme that stimulates the growth of cancer cells. To incorporate the benefits, try adding tangerine zest to your tea or sprinkle it on a salad for a citrusy twist.
Share your thoughts with us we look forward to hearing your comments.
Dr. Willian Julien
Dr. William Julien is a board-certified vascular interventional radiologist and the president of South Florida Vascular Associates. He specializes in minimally invasive procedures to treat conditions like PAD, BPH, uterine fibroids, varicose veins, and aortic aneurysms. Dr. Julien earned his medical degree from Washington University School of Medicine and completed his residency at the University of Minnesota Medical Center, followed by fellowship training at the Miami Cardiac and Vascular Institute. He is certified by the American Board of Radiology with a subspecialty in interventional radiology. Dr. Julien is a member of RSNA and the American Heart Association’s CVRI Council and serves on the Society of Interventional Radiology’s Practice Affairs Committee. He is involved in national device trials and speaks regularly at endovascular conferences. His outpatient endovascular suite is one of the first of its kind in the U.S., allowing patients to receive advanced care outside the hospital.
